Evidence map›Paper›PMID 33427415›Full record

ArticlePhysiological reports2021

Kv1.1 potassium channel subunit deficiency alters ventricular arrhythmia susceptibility, contractility, and repolarization.

Krystle Trosclair, Man Si, Megan Watts, Nicole M Gautier, Niels Voigt, James Traylor, Miklós Bitay, Istvan Baczko, Dobromir Dobrev, Kathryn A Hamilton and 3 more

Open access · goldAbstract read
In one paragraph

Article in Physiological reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Kv1.1 channels help set the pace.The Journal of general physiology · 2024
    Article
  6. IncreasedInternational journal of cardiology. Heart & vasculature · 2023
    Article
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Krystle TrosclairDepartment of Cellular Biology & Anatomy, Louisiana State University Health Sciences Center, Shreveport, LA, USA.ORCID 0000-0003-1189-2377
Man SiDepartment of Cellular Biology & Anatomy, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
Megan WattsDepartment of Internal Medicine, Section of Cardiology, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
Nicole M GautierDepartment of Cellular Biology & Anatomy, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
Niels VoigtInstitute of Pharmacology and Toxicology, University Medical Center Goettingen, Goettingen, Germany.
James TraylorDepartment of Pathology, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
Miklós BitayDepartment of Cardiac Surgery, 2nd Department of Medicine and Cardiology Center, University of Szeged, Szeged, Hungary.
Istvan BaczkoDepartment of Pharmacology and Pharmacotherapy, Interdisciplinary Excellence Centre, University of Szeged, Szeged, Hungary.
Dobromir DobrevInstitute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany.
Kathryn A HamiltonDepartment of Cellular Biology & Anatomy, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
Md Shenuarin BhuiyanDepartment of Pathology, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
Paari DominicDepartment of Internal Medicine, Section of Cardiology, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
Edward GlasscockDepartment of Cellular Biology & Anatomy, Louisiana State University Health Sciences Center, Shreveport, LA, USA.ORCID 0000-0001-8702-2349
Louisiana State University Health Sciences Center Shreveport · USUniversity of Szeged · HUGerman Centre for Cardiovascular Research · DESouthern Methodist University · USWest German Heart and Vascular Center Essen · DE

Funding

Sigmar1 in lipid metabolismR01HL145753 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI BHUIYAN, MD. SHENUARIN · 2019 to 2023
$2.6M
Respiratory mechanisms of epilepsy with high risk of SUDEPR01NS100954 · NINDS · SOUTHERN METHODIST UNIVERSITY · PI GLASSCOCK, ALBERT E · 2017 to 2021
$1.6M
Neurocardiac mechanisms of epilepsy with high risk of SUDEPR01NS099188 · NINDS · SOUTHERN METHODIST UNIVERSITY · PI GLASSCOCK, ALBERT E · 2017 to 2020
$1.3M
Sigma-1 receptor and cardioprotectionR00HL122354 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI BHUIYAN, MD. SHENUARIN · 2015 to 2017
$747k
Sigma-1 receptor and cardioprotectionK99HL122354 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI BHUIYAN, MD. SHENUARIN · 2014 to 2015
$263k
NHLBI NIH HHS K99 HL122354NHLBI NIH HHS R00 HL122354NHLBI NIH HHS R01 HL145753NIH HHS 2018NIH HHS 20391-3NIH HHS HL122354NIH HHS HL145753NIH HHS NS099188NIH HHS NS100954NINDS NIH HHS R01 NS099188NINDS NIH HHS R01 NS100954
6 · The paper itself

Abstract

Epilepsy-associated Kv1.1 voltage-gated potassium channel subunits encoded by the Kcna1 gene have traditionally been considered absent in heart, but recent studies reveal they are expressed in cardiomyocytes where they could regulate intrinsic cardiac electrophysiology. Although Kv1.1 now has a demonstrated functional role in atria, its role in the ventricles has never been investigated. In this work, electrophysiological, histological, and gene expression approaches were used to explore the consequences of Kv1.1 deficiency in the ventricles of Kcna1 knockout (KO) mice at the organ, cellular, and molecular levels to determine whether the absence of Kv1.1 leads to ventricular dysfunction that increases the risk of premature or sudden death. When subjected to intracardiac pacing, KO mice showed normal baseline susceptibility to inducible ventricular arrhythmias (VA) but resistance to VA under conditions of sympathetic challenge with isoproterenol. Echocardiography revealed cardiac contractile dysfunction manifesting as decreased ejection fraction and fractional shortening. In whole-cell patch-clamp recordings, KO ventricular cardiomyocytes exhibited action potential prolongation indicative of impaired repolarization. Imaging, histological, and transcript analyses showed no evidence of structural or channel gene expression remodeling, suggesting that the observed deficits are likely electrogenic due to Kv1.1 deficiency. Immunoblots of patient heart samples detected the presence of Kv1.1 at relatively high levels, implying that Kv1.1 contributes to human cardiac electrophysiology. Taken together, this work describes an important functional role for Kv1.1 in ventricles where its absence causes repolarization and contractility deficits but reduced susceptibility to arrhythmia under conditions of sympathetic drive.

Indexed as

Myocardial ContractionAction PotentialsAnimalsArrhythmias, CardiacDisease Models, AnimalHeart VentriclesKv1.1 Potassium ChannelMiceMice, KnockoutKcna1 protein, mouseKv1.1 Potassium Channelaction potentialarrhythmiacontractilityK-channelrepolarization

Identifiers

PMID33427415
PMCPMC7798052
OpenAlexW3120982983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.